Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus by Foulkes, J. Gordon et al.
THE JOURNAL OF BIOLOGICAL CHEMISTRY 
0 1985 hy The American Society of Biological Chemists, Inc. 
Vol. 260, No. 13, Issue of July 5, pp. 8070-8077, 1985 
Printed in U. S.A. 
Purification  and  Characterization of a Protein-Tyrosine  Kinase 
Encoded  by the Abelson Murine  Leukemia Virus* 
(Received for publication, November 13, 1984) 
J. Gordon FoulkesSP, Marie Chow$1, Carolyn  GorkaS, A. Raymond Frackelton, Jr. 11, and 
David  Baltimore$ 
From the  $Whitehead  Institute for Biomedical Research, Cambridge, Massachusetts 02142 and the Department of Biology, 
Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 and the 11 Department of Medicine, Roger Williams 
General Hospital and Brown University, Providence, Rhode Island 02908 
Sequences  termed  v-abl,  which  encode the  protein- 
tyrosine  kinase  activity of Abelson murine  leukemia 
virus, have been expressed in Escherichia coli as a 
fusion product (ptabl50 kinase). This fusion protein 
contains 80 amino  acids of SV40 small  t and  the 403 
amino  acid  protein  kinase  domain of v-abl. We report 
here  the  purification  and  characterization of this  ki- 
nase. The  purified  material  contains  two  proteins (M. 
= 59,800 and 57,200), both of which possess sequences 
derived from v-abl. Overall purification was 3,750- 
fold, with a 31% yield,  such that 117 pg of kinase could 
be  obtained  from 40 g of E. coli  within 6-7 days. The 
specific kinase  activity is over 170 pmol of phosphate 
min” pmol”, comparable  to the most active  protein- 
serine  kinases.  Kinase  activity is insensitive  to K+, Na+, 
Ca2+,  Ca2+-calmodulin, CAMP, or CAMP-dependent 
protein  kinase  inhibitor.  The K,,, for  ATP is dependent 
on the  concentration of the second substrate.  GTP  can 
also be used as a phosphate donor. The enzyme can 
phosphorylate peptides consisting of as few as two 
amino acids and, at a very low rate, free tyrosine. 
Incubation of the kinase with [-y-”P]ATP results in 
incorporation of 1.0 mol of phosphate/mol of protein. 
This reaction, however, cannot be blocked by prior 
incubation  with  unlabeled ATP.  Incubation of 32P-la- 
beled kinase  with  either ADP or ATP  results  in  the 
synthesis of [32P]ATP. This  suggests the phosphotyro- 
sine residue on the Abelson kinase contains a high 
energy  phosphate bond. 
The  protein  products of several RNA  tumor  virus  trans- 
forming  genes have  been shown to  contain regions that  act as 
tyrosine-specific protein  kinases (1, 2). Similar  kinase  activi- 
ties are also associated with the membrane receptors for 
epidermal growth factor (EGF’) (3), platelet-derived growth 
factor (4, 5 ) ,  insulin-like growth factor (6, 7),  and  insulin (8- 
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11). These findings  suggest that  phosphorylation of certain 
proteins on tyrosine residues, both by oncogene products  and 
by normal cellular  growth factors, is involved in  the  control 
of cell growth. Although numerous phosphotyrosine-contain- 
ing proteins have been observed in cells (1, 5, 12-14) and 
several proteins  have been  shown to  act as substrates i n  vitro 
(8, 13-16), physiologically important targets for these en- 
zymes have yet  to  be  established  in  any s stem. 
Previous  studies  in  our  laboratory  have  concentrated  on  the 
Abelson murine  leukemia  virus (A-MuLV), which encodes  a 
transforming protein with tyrosine-specific kinase activity 
(17, 18). The gene  encoding this  protein  is a fusion of coding 
sequences  from the Moloney murine leukemia virus gag pro- 
tein  and a portion of the cellular  c-abl gene, called v-ab1 (the 
oncogene of A-MuLV)  (19). Systematic  deletions of the v-abl 
gene have defined the minimum region required for both 
kinase  activity  and  fibroblast  ransformation.  These  se- 
quences encode  a M, = 45,000 protein (20).’ 
To gain further insight into the mechanism whereby A- 
MuLV induces cell transformation, we have transferred  the 
DNA sequences  encoding the  minimal  kinase  domain of A- 
MuLV into a vector  which allows expression in Escherichia 
coli (21). In  this  paper, we report a procedure for purifying 
this A-MuLV kinase  to homogeneity, and  present a charac- 
terization of its  enzymatic  properties. 
EXPERIMENTAL PROCEDURES 
Materials-DE52-cellulose and p81 phosphocellulose paper were 
purchased from Whatman. Hydroxylapatite, Affi-Gel Blue, SDS- 
polyacrylamide gel molecular weight markers, and silver stain for 
proteins were from Bio-Rad. Angiotensin 11, ATP, ADP, GTP, kemp- 
tide (leu-Arg-Arg-Ala-Ser-Leu-Gly), Tris, ampicillin, and bovine 
serum albumin (M,  = 67,000)  were obtained from  Sigma. Except for 
bovine serum albumin, the other  proteins used as molecular weight 
markers on gel filtration were obtained from Boehringer Mannheim 
and included cytochrome c (horse heart, M, = 13,370), peroxidase 
(horseradish, M,  = 43,000), alcohol dehydrogenase (yeast, M, = 
143,000), and glutamate dehydrogenase (beef liver, M,  = 1,015,000, 
used for the determination of Vo). Yeast extract and tryptone were 
from Difco. Serine, tyrosine, Arg-Tyr, Lys-Tyr-Lys, Lys-Ser-Tyr, and 
Coomassie  G-250  were  from Serva. [T-~’P]ATP  and  [T-~’P]GTP were 
from ICN East Pharmaceuticals. Brij 35 (polyoxyethylene lauryl 
ether) and ethylene glycol were obtained from Fisher. PIPES and 
HEPES were both Ultrol grade from Calbiochem-Behring. Autora- 
diography was carried out using DuPont Cronex Xtra-Life  intensi- 
fying screens and Kodak XAR-5 film. All other reagents were reagent 
grade or better. 
work: Buffer A = 50 mM PIPES, pH 7.5,  0.1 mM EDTA, 0.015% Brij 
Buffer Solutions-The following buffers were used during this 
35; Buffer B = 20 mM PIPES, pH 8.15, 0.1 mM EDTA, 0.015% Brij 
Prywes, R., Foulkes, J. G., and Baltimore, D. (1985) J.  Virol., in 
press. 
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Characterization of an A-MuLV Protein-Tyrosine  Kinase 8071 
35,  20% ethylene glycol, 0.2% P-mercaptoethanok Buffer c = 20 mM 
Tris-HCI, pH 8.8 (0 "C), 0.015% Brij 35, 20% ethylene glycol, 0.2% 
@-mercaptoethanol, 100 mM NaCI; Buffer D = 50 mM PIPES,  pH 
7.5, 0.1 mM EDTA, 0.015% Brij 35, 10% ethylene glycol, 0.2% @- 
mercaptoethanoi; Buffer E = 50 mM PIPES,  pH 7.5,O.l mM EDTA, 
0.015% Brij 35, 20% ethylene glycol, 2 mM dithiothreitol, 200 mM 
NaCI; Buffer F = 50 mM HEPES,  pH 7.0, 0.1 mM EDTA, 0.015% 
Brij 35,20% ethylene glycol, 0.2% ~-mercaptoethanol; Buffer  G = 50 
mM PIPES,  pH 7.5,  0.1 mM EDTA, 0.015% Brij 35, 0.2% @-mercap- 
toethanol, 20 mM NaCl, 100 mM sucrose; Buffer H = SO mM PIPES, 
pH 7.5, 0.1 mM EDTA, 0.015% Brij 35, 40% ethylene glycol, 2 mM 
dithiothreitol, 100 mM KCl; bacterial media = 25 mM potassium 
phosphate, pH 7.5, containing (per liter) 4.37 g of NHICl, 20 g of 
glucose, 10  g of tryptone, 5 g of yeast extract, 5 g of NaCl, 50 mg  of 
ampicillin, 232  mg  of M e ,  11 mg of Ca2+, 10 mg of Fez+, 0.4 mg of 
MnZ+, 2 mg  of Zn2+, 0.04  mg  of Co2+. 
Expression of Abelson (ptabl50) Kinase Activity in E. coli-Con- 
struction of the expression vector containing v-ab1 sequences has been 
described in  detail elsewhere (21). In brief, sequences coding for the 
kinase domain of A-MuLV were transferred onto a vector which 
allows expression in E. coli. This vector, pCS4, contains the P, 
promoter of X bacteriophage, a ribosome-binding sequence, and  an 
ATG codon, followed  by  0.24 kilobase pairs of sequences coding for 
small t of simian virus 40 (22).  In  addition,  a  temperature-sensitive 
cI gene is present such that transcription from the P, promoter is 
repressed at  30 "C and induced at  42  "C. To  this vector, sequences 
coding for  a specific N-terminal region of the A-MuLV kinase (from 
the HincfI site at  the gag-ab1 junction to  the first PstI  site 1.2 kilobase 
pairs downstream) were placed in-frame behind the small t sequences. 
Thus  at  the permissive temperature, this plasmid expressed a fusion 
protein,  termed the pta6ffiO kinase, which consists of 80 amino acids 
of small t, 403 amino acids form the N-terminal domain of the viral 
Abelson kinase, and 5 amino acids at  its C  terminus from pBR322. 
Bacteria were grown in a New Brunswick Scientific fermentor. 
Medium (9.51) was inoculated with 100 ml of an overnight culture 
grown at 30 "C. Bacteria were grown for 7  h a t  30 'C (until Am = 
4.0). followed by 4 h at 42.5 "C (final Asso = 13). Bacteria were 
harvested by centrifugation (12 min, 6500 X g),  quick-frozen, and 
stored at -70 "C in 6 X 40-g aliquots. 
Assay for ptabl50 Protein-Tyrosine Kinase Activity-Protein con- 
centration was determined by the method of Bradford (23) using 
bovine serum albumin as a  standard. 
ptabl50 kinase activity was measured by the incorporation of 32P 
from [y-'*P]MgATP into angiotensin 11. The standard assay con- 
sisted of 10 p1 of  ptabE50 kinase (in 0.1 mg/ml bovine serum albumin, 
0.2% @-mercaptoethanol  in Buffer A), 10 pl  of angiotensin I1 (3 mg/ 
ml in Buffer A) and was initiated by the addition of 10 p1 of 15 mM 
M8+, 0.3 mM [y3'P]ATP (1,500-10,000 cpm/pmol). After 30 min at  
30  "C, the reaction was terminated by the addition of 120 &l of 10% 
(v/v) phosphoric acid. Each reaction tube was vortexed, and within 
10 min, 120 '1 of the reaction mixture was spotted onto phosphocel- 
idose paper (2 cm square). Papers were washed extensively in 6% 
(v/v) acetic acid, washed once in acetone, dried, and counted. One 
unit of ptabffi0 kinase activity is defined as 1 pmol of phosphate 
transferred from ATP  to angiotensin II/min  in the  standard assay. 
Purification of ptabl50 Kinase-A 40-g aliquot of bacteria was 
thawed on ice, washed once in 100 mM NaC1, 20 mM Tris-HC1, pH 
8.8 (0 "C), 2 mM EDTA, and  then lysed by sonication (4 X 30 s) in 
300 ml of 40 mM NaCI, 1 mM EDTA, 100 mM sucrose, 0.015% Brij 
35,20 mM Tris-HC1, pH 8.8 (0 'C), 0.2% 6-mercaptoethanol. Extracts 
were clarified by centrifugation (190,000 X g, 45 min), and the 
supernatants were applied batchwise to DE52 (220 g, wet weight) 
equilibrated in Buffer B. The DE52 was washed with Buffer 2, 20 
mM NaCl, and ptab150 kinase eluted by the application of Buffer B, 
120 mM NaC1, 2 mM MgCI2. 
This preparation was applied batchwise to hydroxylapatite (400 g, 
wet  weight, pre-equilibrated in Buffer C), the resin was then washed 
with Buffer C, 35 mM phosphate, and ptabWO kinase eluted with 
Buffer C,  120 mM phosphate. The preparation was concentrated using 
Amicon stirred cells (YM-10 membranes) and dialyzed overnight 
against  Buffer D. The next day, the material was applied to  an Affi- 
Gel Blue column (50 ml bed volume) equilibrated in Buffer D, the 
column was washed with Buffer D, 220 mM NaCl, and  the  kinas 
eluted by the addition of Buffer D, 860 mM NaCl. The 10% ethylene 
giycoi concentration in Buffer D allows the kinase activity to bind to 
the Affi-Gel Blue column. A t  20% ethylene glycol, no binding was 
observed. Kinase activity was concentrated using an Amicon stirred 
cell (YM-10 membranes) and at the end of the second day, was 
applied to a Sephadex G-100 superfine column (2.6 X 95 cm, flow 
rate 8 ml h-*) equilibrated in Buffer E. Fractions  eluting from the 
column which contained kinase activity were pooled and dialyzed 
against Buffer F.  The preparation was then applied to a Spherogel 
TSK DEAE-3SW high pressure liquid chromatography column (7.5 
x 75 mm). The column was washed with Buffer F, 100 mM NaC1, 
and  the kinase activity  eluted with a 100-250 mM NaCl gradient (in 
Buffer F), 0.7 mi  min"  flow rate, with a total gradient volume of 120 
mf. 
Fractions containing kinase activity were pooled and dialyzed 
against Buffer G. The final purification step employed an anti- 
phosphotyrosine monoclonal antibody (MA-2G8) coupled covalently 
to Sepharose 4B (12). The preparation was applied to  this column (2- 
ml bed volume), the column was  washed with Buffer G, and kinase 
activity eluted by the addition of Buffer G, 2 mM phenyl phosphate 
(as a tyrosine phosphate analogue), 
The final preparation was dialyzed against Buffer H and stored 
either at -20  "C, or quick-frozen and stored at -70 "C. The enzyme 
was stored in  a dithiothreitol-containing buffer for long term stability. 
RESULTS 
Purification of ptabWO Kinase-Sequences encoding the 
minimal kinase domain of A-MuLV  were transferred  into the 
vector pCS4, which allows expression in E. coli. This construct 
produces a fusion protein containing sequences derived from 
both small t protein of SV40 and  the v-ab1 transforming gene 
which we have termed the p ~ b ~ 5 0  kinase. The function of 
small t sequences in  this construct was to increase the degree 
of expression in E. coli (21). 
Purification of the  ptub~50 kinase activity is summarized in 
Table I, based on a starting  preparation of 40 g of E. coli 
Preliminary experiments revealed the presence of at least five 
forms of the ptabZ50 kinase which separated at various stages 
of the purification. Although all forms migrated reproducibly 
when rechromatographed, the ratio of the forms varied with 
different fermentations. Therefore, Table I represents aver- 
aged data obtained from multiple fermentations, with the 
data normalized with respect to  the two forms which were 
purified (see below). These two forms constituted 35% of the 
total activity in the  extract so that  the actual specific activity 
of the  extract was 206 k 11 units mg" of protein (n = 10): 
The various forms that were not purified were found in the 
following fractions: 3-25%4 in  the DE52-20 mM NaCl fraction, 
22-48% in the hydroxylapatite-35 mM phosphate fraction, 6- 
60% in  the Affi-Gel  Blue-210 mM NaCl fraction, and 10% in 
the breakthrough of the anti-phosphotyrosine column. 
On gel ~ltration,  the nzyme moved as a monomer (Mr = 
60,300 f 700 (a  = 3)).  In  the absence of NaCl in  the column 
buffer, 25% of the enzyme moved with an apparent M, = 
125,000, and this form of the enzyme could be partially 
dissociated (up to 50%) to  the M, = 60,300 form if rechro- 
matographed in the presence of  200  mM NaCl (data not 
shown). 
The Abelson kinase is capable of an autophosphorylation 
reaction on tyrosine residues (17,18,24-26). We hoped to use 
this property as a purification step, by preincubating the 
enzyme with ATP followed by chromatography through an 
anti-phosphotyrosine monoclonal antibody column (12). Pre- 
liminary experiments revealed, however, that  the two forms 
of ptabl50 kinase, as isolated in Step 5 and onward, were 
already phosphorylated, because over 80% of the activity was 
recovered in the fraction which bound specifically to the 
column even without preincubation with ATP. The 10% 
appearing in  the breakthrough fraction of the column proba- 
' Data presented in this manner  represent the mean f standard 
'These figures represent the range of activities found in these 
error, followed by the numher of determinations (n) in parentheses. 
fractions with various fermentations. 
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8072 Characterization of an A-MuLV Protein-Tyrosine  Kinase 
bly represented dephosphorylated forms of the enzyme,  be- 
cause on rechromatography, over 80% of this activity was 
again recovered in the breakthrough. 
Criteria of Purity-The purified preparation  (Step 7) was 
subjected to polyacrylamide gel electrophoresis (27), followed 
by silver staining (28) to determine the number of proteins 
present (Fig. 1). Using either low (35 ng) or high (425 ng) 
amounts of protein, two bands were apparent. At the high 
protein loading (Fig. 1, lane 3), one minor and two  very faint 
bands of lower  molecular  weight  were also observed. Whether 
these represent breakdown products or minor contaminants 
was not determined. The lower protein loading (Fig. 1, lane 
2) showed that  the slower migrating band represented the 
predominant species. The intensity of silver staining for 35 
ng of ptubl50 kinase (as estimated by the method of Bradford 
(23))  is in reasonable agreement with the 40 ng loaded for 
each protein standard (compare Fig. 1, lanes 1 and 2). 
In comparison to proteins of known  molecular  weight  (Fig. 
1, lane 1 ), the two major bands have a M, = 59,800 and 57,200. 
Based on an apparent M, = 60,300 on gel filtration, the 
enzyme appears to be a monomer. These estimates of the 
molecular  weight are  in good agreement with a theoretical M, 
= 56,000 based on the known  DNA  sequence. 
To examine the immunological parameters of the enzyme, 
portions of the preparation from Step 7 were incubated with 
5 mM Mg+, 100 p M  [T-~~PJATP for 30 min at 30 "c. One 
reaction was terminated by the addition of 15 mM EDTA, 
while  two others were immunoprecipitated by the addition of 
a monoclonal antibody directed against small t protein of 
SV40 (antibody 419, kindly provided by Dr. Ed Harlow,  Cold 
Spring Harbor Laboratory) or with a polyclonal serum against 
v-abl-specific sequences (29). All three samples were subjected 
TABLE I 
Purification of ptubW0 kinase 
Step Volume Units Protein  Specific activity Yield  Purification 
ml 
1. Extract 300 
2. DE52 3,000 
3. Hydroxylapatite 3,000 
4. Affi-Gel Blue 850 
5. Sephadex G-100 superfine 17 
7. Anti-phosphotyrosine 6 
6. TSK DEAE-3SW 10 
1 2  
Mr x I O ' ~  
pmol min" mg 
101,990 1,412 
95,870 393 
90,120 108 
75,600 33 
54,050 7 
37,840 1.37 
31,620 0.117 
3 
974 - - 
66.2 4 
- - -  
4 5  
units mg" 96 -fold 
72 100 1 
244 94  3.4 
834 88 11.6 
2,320 75  32 
7,720 53  107 
27,620 37  384 
270,000 31 3,750 
6 7 8  
43.9 - - 
30.5 - - 
21.5 - - 
FIG. 1. SDS-polyacrylamide gel electrophoresis of purified  ptubl50 kinase. Portions of the purified 
enzyme (from Step 7) were subjected to SDS-polyacrylamide gel electrophoresis (10% gel), followed by silver 
staining. Lane I represents  protein  markers of known molecular weight, with 40 ng of each marker loaded. Lane 
2, 35 ng and lane 3, 425 ng of the purified ptab150 kinase. Lanes 4-8 represent an autoradiograph of the ptabl50 
kinase, incubated with [y3*P]MgATP,  and subjected to SDS-polyacrylamide gel electrophoresis. Lane 4, ptabl50 
kinase incubated with MgATP. Lanes 5-8, ptabl50 kinase 32P-labeled and immunoprecipitated with either 
preimmune serum ( l a n e  5) followed by immune Abelson-specific serum ( l a n e  6), or a nonspecific monoclonal 
antibody ( l a n e  7) followed  by specific small t monoclonal antibody ( l a n e  8) .  Immunoprecipitates were collected 
with Staphylococcus  aureus and washed in 1 mM EDTA, 1% deoxycholate, 0.1% SDS, 100 mM NaCI,  50 mM Tris- 
HC1, pH 8.0, prior to dissociation with sample buffer. Further details are provided in the text. 
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Characterization of an A-MuLV Protein-Tyrosine Kinase 8073 
to SDS-polyacrylamide gel electrophoresis. In the sample 
treated with [T-~~P]ATP alone, two phosphorylat~ bands 
were evident (Fig. 1, lane 4 )  which co-migrakd with the two 
major protein bands visualized by silver staining (Fig. 1, lanes 
2 and 3).  Phosphoamino acid analysis (30) of these two bands 
revealed phosphotyrosine as the exclusive amino acid phos- 
phate acceptor (data  not shown). Immunoprecipitation with 
a nonspecific monoclonal antibody (Fig. 1, lane 7) or preim- 
mune  mouse serum (Fig. 1, lane 5) demonstrated the absence 
of nonspecific binding, while both phosphorylated bands were 
immunoprecipitated by the addition of either  v-dl-specific 
serum (Fig. 1, lane 6 )  or  the anti-small t monoclonal antibody 
(Fig. 1, lane 8). Thus,  the purified enzyme is a small t-v-dZ 
fusion protein as expected from the sequences in  the plasmid 
expressed in E. coli. 
The  puri~cation scheme, as summar iz~  in  Table I, allowed 
117  pg  of essentially homogeneous  ptabl50 kinase to be ob- 
tained from 40 g of E. coli within 6-7 days. Stored at -20 "C 
in Buffer H,  the nzyme lost less than 20% of its activity over 
4 months. Enzyme activity also survived  quick-freezing and 
storage at -70 "C, but the long term stability under these 
conditions was not determined. 
KinettC Properties-All  of the following reactions were car- 
ried out using the  Step 7 purified ptabl50  kinase. In a standard 
assay with angiotensin (1 mg  m1-l) as the substrate, the kinase 
activity was stable, and phosphate incorporation was linear 
for at least 45  min. In addition, incorporation was linear up 
to at least 40 pmol of phosphate. The  pH optimum for this 
reaction was pH 7.5, with greater than 50% of the maximal 
activity expressed over the range p H  6.5-8.5. 
A number of protein-tyrosine kinases, including the AbeI- 
son kinase, show an apparent preference for  Mn2+ ions over 
M F ,  at least when their kinase activity is measured  using 
partially purified preparations (1, 4, 17, 32, 33). It has been 
suggested that  this may be due to  the ability of Mn2+ ions, 
but  not M$+ ions, to inhibit protein-tyrosine p h o s p h a ~ ~ s ,  
present as contaminating activities in crude systems (34,35). 
With purified ptabl5O kinase, Mn2+ ions were found to be only 
partially effective  (Fig. 2), with iess than 20% of the activity 
expressed compared to that observed at saturating concentra- 
tions of MgZ+ ions. Half-maximal activity was observed at 1.5 
mM M e  ions. 
The inclusion of either K+ or Na' ions (up to 250 mM) in 
the  standard assay had no effect. Increasing ionic strength 
has been reported to inhibit other protein-tyrosine kinases 
201 J 
Metal ion concentration imM1 
FIG. 2. The effect of M 8 '  and Mn"* ions on the activity of 
the ptablfiO kinase. Incubations were carried out under standard 
assay  conditions (1 mg ml" of angio~nsin Ii, 100 &M ATP, 30 min, 
30 "C, 10 units ml" of ptobls0 kinase)  in the presence of either MgZf 
ions (0) or Mn2+ ions (0). Activity is expressed as a percentage of 
the maximum kinase activity observed at  saturating concentrations 
of M P  ions (5 mM M&l& No kinase activity was observed in the 
absence of Mg2' ions. 
(15, 36) but the degree of inhibition is dependent on the 
substrate employed  (37). In  the absence of Mg"', Ca2+ ions 
(over the range 0.1-5.0  mM) failed to support enzyme activity. 
In  the  standard assay, the addition of either Ca2+-calmodulin 
(10-200 pM ea2" and up to 1 pM calmodu~in), CAMP (0.1-100 
p ~ ) ,  or the specific heat-stable protein inhibitor of the CAMP- 
dependent protein kinase (at levels which produce greater 
than 95% inhibition of the CAMP-dependent kinase) had no 
effect on the activity of the p~bl.50 kinase. 
We have also determined the kinetic parameters for a 
number of substrates under our standard assay conditions 
(Table 11). For these experiments, preliminary values of the 
K,,, were estimated from  two substrate concentrations using 
the Eisenthal-Cornish-Bowden plot (38). We then determined 
K,,, and V using a series of substrate concentrations, spanning 
up to a 10-fold range around the estimated Km, For all sub- 
strates, linearity with respect to both time and enzyme  con- 
centration was established. Each data  point was performed in 
triplicate. Data were then analyzed by a least-squares fit to a 
hyperbola of V Versus [SI measurements (39,401, and by the 
computerized direct linear method (38, 41). The results from 
both methods were  weight-averaged to give the  data in Table 
11. 
For angiotensin 11, the K,,, was 3.7 & 0.3 mM (Table 11). 
The K,,, for ATP was  found to be dependent on the concen- 
tration of angiotensin 11, measured as 39 pM at 0.95 mM 
angiotensin and 100 p~ at 11.47 mM angiotensin 11. From the 
turnover rates for ATP at these two concentrations of angi- 
otensin 11, one can calculate the Km for an~otensin 11, at 
saturating concentrations of ATP, to be 15.8 mM. The de- 
pendence of the apparent K, for one substrate on the concen- 
tration of the second  suggests that  the binding sites for the 
two substrates overlap. 
The turnover number of  170 pmol  min"  pmol"  of ptdl50 
kinase, determined for ATP at high  levels of a~giotens~n I1 
(Table II), is  comparable to  the specific activity of the most 
active protein-serine kinases (42-44). To date, the highest 
turnover numbers reported for other protein-tyrosine kinases 
are (calculation based on B 30 "C incubation) 15-30 pmol 
min" pmol" for the insulin receptor (8, 45, 46), 7-55 pmol 
min" pmol-1 for the  EGF receptor (45, 47), and 2-3 pmol 
min-'  pmol" for the transforming protein of Rous  sarcoma 
virus p p W ,  (15, 16). 
ptabl.50 kinase can use GTP  as the phosphate donor (Table 
TABLE I1 
Kinetic constants for substrates of ptabl5O kinase 
Substrate K ,  Turnover number 
p m L  min" mg" 
kinose 
1. Angiotensin I1 3.7 t 0.3" 
(at 100 PM ATP) 
1.25 t 0.05 
2. ATP  (at 0.956 mM 0.039 k 0.001 0.38 t 0.02 
angiotensin XI) 
3. ATP (at 11.47 mM 0.100 t 0.003 2.82 f 0.03 
4. GTP  (at 0.956 mM 
angiotensin 11) 
0.3 t 0.04 0.19 f 0.02 
angiotensin 11) 
5. Lys-Tyr-Lys (at 
100 /.tM ATP) 
12 t 1.2 0.11 f 0.004 
6. ArgTyr (at 100 
+M ATP) 
36 It 5 0.1 4- 0.007 
7. Tyr  (at 100 NM NDb 
ATP) 
-0.00026' 
Values represent mean f S.E. 
Determined at 0.2 mg ml" of tyrosine. 
mM 
* ND, not determined. 
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8074 Characterization of an A-MuLV Protein-Tyrosine  Kinase 
11), but the K,,, is nearly 8-fold  higher and  the turnover number 
2-fold lower than the corresponding values determined for 
ATP. GTP supports the activity of  pp60"" (16) and possibly 
the platelet-derived growth factor receptor (4). In contrast, 
the protein-tyrosine kinase activities associated with the 
transforming protein of Snyder-Theilen feline sarcoma virus 
(48), the insulin receptor (33,49),  as well as a tyrosine kinase 
isolated  from normal rat liver (37), all appear to have a  strict 
requirement for ATP. The situation with the  EGF receptor 
remains to be clarified (45,50-52). 
Because angiotensin 11, an octapeptide, appeared to be a 
good phosphate acceptor, we  were interested to determine the 
minimum  size of peptide which  would  serve as  a substrate. 
Table I1 shows that peptides containing either  three or two 
amino acids or even  simply free tyrosine could also be phos- 
phorylated, although the  latter  substrate is particularly inef- 
fective. 
Specificity of ptabWO Kinase for Tyrosine  Residues-Incu- 
bation of the ptabl50 kinase with a variety of protein sub- 
strates  and  a number of different peptides, followed  by phos- 
phoamino  acid analysis, revealed that phosphotyrosine was 
the exclusive amino acid phosphate acceptor (data not 
shown). Incubation of the peptide Lys-Ser-Tyr with a high 
concentration of the ptabl50 kinase, followed by phosphoa- 
mino  acid analysis, revealed trace amounts of phosphoserine 
(Fig. 3, A and B ) ,  but such low levels could be derived 
nonenzymatically  from the adjacent phosphotyrosine during 
preparation. To examine critically whether serine residues 
can be substrates for the ptabl50 kinase, we used the peptide 
Leu-Arg-Arg-Ala-Ser-Leu-Gly, which  does not contain tyro- 
sine residues. Incorporation of 32P suggested a very low rate 
of phosphorylation, approximately of the  rate observed 
with angiotensin 11. Surprisingly, however, phosphoamino 
acid analysis revealed  only phosphotyrosine (Fig. 3C), indi- 
A 0 
i :"@-s .. **, . . .-@-s . .*  .. 
8-T": 
C 
*+@-Y 
' "-.c 
FIG. 3. Phosphoamino acid analysis  of substrates for 
ptabl50 kinase. A and B,  12.5 units of ptabl50 kinase was incubated 
with 25  pg  of Lys-Ser-Tyr and 100 p~ [y3'P]ATP (20,000 cpm 
pmol") in 30 pl for 60 min at  30  "C. The phosphorylated peptide was 
purified by paper electrophoresis (pH 3.5, 2,400 V, 90 min), eluted, 
and subjected to acid hydrolysis (6 N HCI, 105 "C, 60 min).  Phospho- 
amino acids were separated by two-dimensional thin layer electro- 
phoresis (12, 30),  internal standard markers were stained with nin- 
hydrin, and 32P-labeled phosphoamino acids were detected by auto- 
radiography. A represents  a 10-h exposure; B,  a 1-month exposure. 
Control incubations containing only peptide and ATP and processed 
as above revealed only traces of 32P associated with serine and 
tyrosine, a t  a level barely detectable above background (data not 
shown). C, 60 units of  ptab150 kinase was incubated with 88.5  pg of 
the peptide Leu-Arg-Arg-Ala-Ser-Leu-Gly and 100 p M  ATP (15,000 
cpm pmol") in 30 pl for 5 h at  30  "C. The reaction was terminated 
by the addition of 100 pl of 10% (v/v) phosphoric acid, and the 
peptide was isolated by spotting the reaction mixture on phosphocel- 
lulose paper and was separated from ATP by washing the paper in 
acetic acid (6%). The peptide was eluted by the addition of ammonium 
hydroxide and lyophilized, and  the phosphoamino acid analysis was 
performed as described above. 
cating that  at least one of the amin6,acids used to synthesize 
the commercially obtained peptide was contaminated with 
traces of tyrosine. An analogue of this peptide, which con- 
tained tyrosine at  position 5 instead of serine, has been 
reported to be phosphorylated by both the EGF (53) and 
insulin (11) receptors. 
Autophosphorylation of ptabl50  Kinase-Most protein ki- 
nases undergo an autophosphorylation reaction when incu- 
bated with  MgATP  (1, 54). Previous work had demonstrated 
that the Abelson kinase can undergo intermolecular auto- 
phosphorylation both in vivo and in  vitro  when  immunopre- 
cipitated from virally transformed cells (25, 26). Earlier in 
this paper, we showed that homogeneous ptab150 kinase, as 
isolated  from E. coli,  could also be autophosphorylated (Fig. 
I), suggesting that  this reaction is not due to  a trace contam- 
inating E. coli protein-tyrosine kinase. The purified kinase 
incorporates about 1.0  mol  of phosphate/mol of enzyme  (Fig. 
4). The autophosphorylation of pp60"" (16, 55), the EGF 
receptor (56), and the insulin receptor (32) has also been 
reported to result in the incorporation of significant amounts 
of phosphate. In the case of pp60"" (57) and the insulin 
receptor (49, 58), autophosphorylation has been correlated 
with activation. An increased  phosphotyrosine content of the 
protein-tyrosine kinase of PRC I1 virus  is  also  associated  with 
an increase in kinase activity (59). The normal v-ab1 protein 
contains two  major sites of tyrosine phosphorylation (26,60- 
62), but  the stoichiometry of phosphorylation has not been 
reported. At an enzyme concentration of  43.6  nM, the rate of 
phosphorylation at  30  "C  was approximately 1.3  nmol  of phos- 
phate min"  mg"  of kinase. This figure  is almost identical to 
the  rate reported for pp60"" autophosphorylation (16). 
In attempting to examine the phosphorylation of other 
proteins of a similar molecular  weight to  the ptabl50  kinase, 
we had thought to mask the autophosphorylation reaction by 
incubating the kinase with unlabeled MgATP prior to the 
addition of exogenous substrate and [32P]ATP. This failed to 
have any effect on the autophosphorylation reaction. To 
examine this failure, we incubated two identical reactions, 
each containing the ptabl50 kinase and MgATP, and  to one 
Q c .- 
/ 
1 1 I 
30 60 90 120 150 
Time (mid 
FIG. 4. Autophosphorylation of ptabl50 kinase. Two tubes 
containing 0.654 pmol of ptabl50 kinase were incubated for various 
times with 0.37 mM ATP, 5 mM M$+ (15-pl reaction, 30 "c). To one 
tube (0), [y3*P]ATP was added at  zero time (final specific activity 
38,000 cpm pmol"). To  the other  tube (0) [y3'P]ATP was added 
after 1 h. Reactions were terminated by the addition of 2 pl of 250 
mM EDTA, and products were then subjected to SDS-polyacrylamide 
gel electrophoresis (10% gels). The ptabl50 kinase was located by 
autoradiography, and  the bands were  excised and counted. 
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Characterization of an A-MuLV Protein-Tyrosine  Kinase 8075 
tube we added trace concentrations of high specific activity 
[y-"2P]MgATP a t  zero time. By 32P incorporation, the  auto- 
phosphorylation  reaction  appeared to have terminated  after 
1 h (Fig. 4). Addition of [ T - ~ ~ P I M ~ A T P   t o  an identical reac- 
tion incubated for 1 h  with  MgATP but without radiolabel, 
however, resulted in 32P incorporation into ptab150 kinase at  
the same rate  and  to  the  same  extent (Fig. 4). It therefore 
appeared that a 32P exchange reaction was occurring in  the 
ptabWO kinase. 
To  further analyze this phenomenon, we incubated ptab150 
kinase with [y-"PIMgATP, filtered the preparation to remove 
ATP,  and  then added EDTA, unlabeled ADP, or unlabeled 
ATP (Fig. 5). Control  incubations  with  EDTA  indicated  no 
.- = 4 0 4  I 
O !  I 1 I 1 I 1 I 
0 15 30 45 60 75 90 
Time (mid  
8 O O -ATP- 0 
FIG. 5. Reversibility of the ptabZ50 kinase autophosphory- 
lation reaction. ptabl50 kinase was incubated overnight at 4 "C with 
[y3'P]ATP (30,000 cpm  pmol"),  followed  by  gel filtration (Sephadex 
G-50 superfine) to remove the ATP. Portions containing 0.24 pmol 
of 32P-labeled ptabl50 kinase were incubated with 10 mM M F ,  1 mM 
ADP, 5 mM M F ,  0.37 mM ATP, or 1 mM EDTA at 30 "C for  various 
times as indicated. The reaction volume  was  15 pl. The reaction was 
terminated by the addition of 2 pl of 200 mM EDTA. A, per cent 
phosphorylation of the protein following incubation with ADP (0) or 
EDTA (A) was determined by subjecting 14 pl of the reaction to  SDS- 
polyacrylamide  gel electrophoresis, locating the 3ZP-labeled kinase by 
autoradiography, excising the 3ZP-labeled bands, and counting. B,  
portions of 1 p1 of the reaction mixture were spotted onto polyethyl- 
eneimine thin layer-cellulose (Macherey-Nagel, Duren, West Ger- 
many), chromatographed with 0.5 M KHzPOI, pH 3.5, as the solvent, 
and [32P]ATP formation was analyzed by autoradiography. Lane I ,  
32Pi  standard; lane 2, [y3'P]ATP standard; lanes 3, 5, 7, and 9, 32P- 
ptabl50 kinase incubated with EDTA for 2, 10, 30, and 90 min, 
respectively; lanes 4, 6, 8, and 10, 32P-ptab150 kinase incubated with 
ADP for 2, 10, 30, and 90 min, respectively; lane 11, 32Pi-labeled 
ptabl50 kinase incubated with ATP (unlabeled, 0.37 mM) for 30 min 
and analyzed for [32P]ATP formation as described above. 
formation of 32Pi (Fig. 5A)  and therefore, the absence of 
phosphotyrosyl-protein phosphatase activities which show 
optimal activity in the presence of EDTA (34). Addition of 
MgADP resulted in the dephosphorylation of the ptabl50 
kinase (Fig. 5A)  and the synthesis of [32P]ATP (Fig. 5B). 
Similarly, addition of unlabeled ATP  to 32P-labeled ptabl50 
kinase  resulted  in the loss of 32P from the protein and  the 
synthesis of [32P]ATP (Fig. 5B, lune 11). The increased 
amount of 32Pi generated in this experiment (Fig. 5B, lune 11) 
demonstrated that  the ptab150 kinase preparation contained 
a very low level of ATPase activity (<0.1 nmol min"  mg"  of 
kinase). Although 32Pi was also observed in the experiments 
with ADP, this was present at  zero time and did not increase 
during incubation. The absence of detectable ATPase presum- 
ably reflects the low concentrations of ATP formed in  these 
experiments carried out with ADP. The CAMP-dependent 
protein  kinase has also been shown to possess a low level of 
ATPase  activity (63). 
DISCUSSION 
We report here the first purification of the protein-tyrosine 
kinase activity encoded by the transforming gene of Abelson 
murine leukemia virus. This is also the first active protein- 
tyrosine kinase to be purified using an expression vector 
system in E. coli. The transforming  protein of Rous sarcoma 
virus has been expressed in E. coli and large quantities of the 
protein were produced, but  the majority of the material proved 
to be insoluble (64,65).  In  contrast,  in our experiments, only 
low concentrations of the Abelson ptabl50 kinase were syn- 
thesized, but the material was in an active, soluble form. 
Purification proved to be difficult because multiple forms 
were found to exist; at  least six species could be separated 
chromatographically. The reason for this is unclear, but some 
of the forms are probably generated as a consequence of 
multiple potential  initiation  sites  in the vector. The different 
forms could also result from variable degrees of phosphoryla- 
tion or proteolytic breakdown products formed during fer- 
mentation. Immunoprecipitation of extracts from radiola- 
beled bacteria (32P or 35S), with antibodies directed against 
the Abelson kinase, also revealed multiple species of ptabl50 
kinase (21). With respect to  the two forms which were puri- 
fied, the overall purification was  3750-fold with a 31% yield, 
such that 117 pg  of ptabl50 kinase was obtained from 40 g of 
E. coli within 6-7 days. Assuming all forms have equal activity, 
the  total ptabl50 kinase in E. coli extracts would represent 
only 0.076%  of the soluble protein. The most powerful puri- 
fication step was the anti-phosphotyrosine monoclonal anti- 
body column, where a 10-fold purification to homogeneity was 
obtained. This column also binds the platelet-derived growth 
factor receptor, the  EGF receptor, and  the p12WW"*' protein 
of A-MuLV (5,12).  This  step could not be used earlier in our 
protocol because expression of the Abelson kinase in E. coli 
results  in the phosphorylation of many bacterial proteins on 
tyrosine (18). A 10-15-fold purification was also possible on 
the ion-exchange high pressure liquid chromatography col- 
umn, but only by accepting a significant reduction in yield 
(data not shown). 
The final preparation contained two major proteins as 
visualized by silver staining following SDS-polyacrylamide 
gel electrophoresis. Both of these  proteins were immunopre- 
cipitated by antibodies directed against either the small t 
antigen region or  the Abelson kinase domain, providing strong 
evidence for their identity as species of ptabl50 kinase. Al- 
though both protein bands become phosphorylated in the 
presence of MgATP, it remains to be shown that both  bands 
possess kinase activity. An earlier purification protocol we 
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8076 C~ructerizut~n of an A - ~ u ~ V  Protein-Tyrosine K i ~ e  
had developed  used a narrow range of salt concentrations to 
elute stepwise the kinase from the Affi-Gel Blue column. This 
procedure resulted in a single species of  ptab150 kinase (data 
not shown), suggesting that the two  forms  can be separated 
by this step. We have yet to determine the exact relationship 
between these two  species. Autophosphorylation of the pro- 
tein-tyrosine kinases associated with either PRC I1 (59) or 
Rous sarcoma virus (55) results in the appearance of two 
forms  on  SDS-polyacrylamide gel electrophoresis. The most 
highly phosphorylated form of each protein has  the slowest 
mobility. 
The use of angiotensin I1 as a phosphate acceptor was based 
on the procedure developed  by  Wong and Goldberg  (66, 67). 
This is a particularly powerful assay as  it allows the measure- 
ment of a protein-tyrosine kinase even in cell extracts, be- 
cause background phosphorylation due to endogenous kinases 
and their substrates can be removed by precipitation with 
trichloroacetic acid under conditions where angiotensin I1 is 
soluble. In E. coli extracts, background phosphorylation is so 
low that the ptabl50 kinase can be measured accurately even 
without the protein precipitation step. 
The high K ,  for angiotensin I1 is not unusual for peptides 
when they are used as substrates for protein-tyrosine kinases 
(11, 44,  50,  53,  67, 68). As suggested by Pike et al. (53), this 
may reflect either incorrect primary sequence determinants 
or the small size of the substrate. Factors other than the 
primary sequence are important for the CAMP-dependent 
kinase (69, 70). There  are some data to suggest that acidic 
residues in  the vicinity of and a basic amino acid 6-7 residues 
N-terminal to the phosphorylated tyrosine may be important 
recognition determinants for protein-tyrosine kinases. There 
are also,  however, clear exceptions to  this rule (13, 62), par- 
ticularly as applied to the Abelson kinase (62, 71). In this 
paper, we have  shown that peptides containing just  three or 
even  two amino acids  could be phosphorylated, as well as free 
tyrosine, although this  latter  substrate is particularly ineffec- 
tive. Both Tyr-Arg and free tyrosine have been tested as 
substrates for a number of protein-tyrosine kinases and were 
not phosphorylated (50,67,68,72). Tyr-Arg is phosphorylat~ 
by  ptabWO kinase but high concentrations are inhibitory (data 
not shown). Limited phosphorylation of Tyr-Arg has also 
been reported for the insulin receptor (73). Tyramine and N- 
acetyltyrosine are phosphorylated by immunoprecipitates 
containing the ~ 1 3 P . ~  protein of Fujinami sarcoma virus 
(72). 
For  all the  substrates of ptabl50 kinase, tyrosine was the 
exclusive amino acid phosphate acceptor. With Lys-Ser-Tyr, 
a very small amount of serine phosphorylation was also ob- 
served, but we consider it unlikely that this was derived 
enzymatically. 
Perhaps all protein kinases, and certainly the Abelson 
kinase, can carry out an autophosphorylation reaction (1,54). 
The ptabl50 kinase must also undergo autophosphorylation 
when expressed in E. coli, because most of the activity binds 
to  the anti-phosphotyrosine monoclonal column. The auto- 
phosphorylation of ptabl50 kinase observed here in uitro (Fig. 
4), however, appears not to be a true phosphorylation, but 
may represent an exchange reaction between the unlabeled 
phosphate present in the ptubWO kinase with 32P from [y-"PI 
ATP. The rate of autophosphorylation would therefore rep- 
resent the rate of exchange and the plateau at 1.0 mol of 
phosphate, the point at which the 32P-specific activity of the 
enzyme  would  be equal to the specific activity of the [y-32P] 
ATP. The purified ptabl50 kinase used in these experiments 
is a monomer,  which binds to the anti-phosphotyrosine mono- 
clonal column, indicating that each molecule of kinase already 
contained at least one molecule of phosphotyrosine prior to 
incubation with MgATP in uitro. The autophosphorylation 
reactions of several protein-serine kinases have also been 
shown to be reversible  (54, 74,  75), and  there is at least one 
example of a phosphotyrosyl-protein where the free  energy of 
hydrolysis of phosphotyrosine was shown to be only slightly 
lower than  that of the terminal phosphate residue in ATP 
(76). The autophosphorylation of ptubl50 kinase could repre- 
sent an equilibrium phenomenon, driven at zero time by the 
enzyme  being  fully phosphorylated, using low levels of ADP 
(present as a contaminant in  ATP or generated by the low 
ATPase activity) to first dephosphoryIate the enzyme, and 
thereby allow subsequent rephosphorylation by [y-32P]ATP. 
Alternatively, the enzyme may simply  bind ATP  and directly 
exchange the y-phosphate of ATP with the phosphate already 
present on the enzyme. Presently, we are performing a de- 
tailed analysis to determine the exact mechanism  involved. 
Recently,  two other activities have  been  found  in  associa- 
tion with protein-tyrosine kinases. First, the EGF receptor 
has been reported to act as  an ATP-stimulated nuclease (77). 
ptabl50 kinase is completely devoid of such an a~t ivi ty .~ 
Second, the transforming proteins pp60"" (78) and pp68"" (79) 
have been found in association with a phosphatidylinositol 
kinase activity. Again, the ptabl50 kinase lacks such an activ- 
ity: The specific activity of purified ptabl50 kinase is over 
170  pmol of phosphate min-l  pmol-', strongly suggesting that 
the ability of this protein to  phosphoryla~ tyrosine residues 
is not a trace enzymatic activity. 
Finally, we have tested CAMP, the CAMP-dependent pro- 
tein kinase inhibitor protein, Ca2', and Ca2+-calmodulin as 
possible regulators of the ptabl50 kinase, all without effect. 
The Abelson kinase we have purified however, represents only 
the catalytic domain (20); it may  lack  regulatory  sequences, 
In this respect, ptabl50 kinase would be analogous to the 
trypsin-derived catalytic fragments of the CAMP- and cGMP- 
dependent protein kinases and protein kinase C,  which retain 
activity but no longer  respond to their normal  physiological 
modulators (80). Protease-resistant but enzymatically active 
domains of pp60"" (81, 82) and p9Ws (81) have also been 
reported. In addition, the N terminus of ptabl5O kinase con- 
tains sequences derived from small t of SV40, while the 
normal viral enzyme contains gag sequences derived from 
Moloney murine leukemia virus (19,ZO)  which  have a myris- 
tate group at their N terminus (83,84). One  might speculate 
that  the modified N terminus of ptabl50  kinase  could result 
in an alteration of substrate specificity, for instance, the 
absence of phosphatidylinositol kinase activity. For both pro- 
tein kinase C (85) and pp60"" (15, 16), evidence exists which 
suggests that alterations of specificity may occur when the 
size of the catalytic domain is altered. By microinjection of 
ptab150 kinase into cells,  however, we have demonstrated that 
the enzyme retains at least some of the biological activities 
associated with the  pro~in-tyrosine kinase encoded by the 
normal v-abl  gene,  namely, the  regu~ation of ribosomal protein 
S6 phosphorylation on serine residues (86) and  the ability to 
induce  morphological transformation of NIH/3T3 fibro- 
b l a s t ~ . ~  
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